VerImmune’s Post

Join the leaders in cancer immunology, present your abstract at CICON24. CIMT is a proud partner of the eighth International Cancer Immunotherapy Conference: Translating Science into Survival.

Ever wonder about the critical role of the tumor-immune microenvironment (TME) in cancer development and treatment? In our webinar on multiplex immunofluorescence (mIF), we will explore this crucial area, a powerful approach that illuminates the intricate tumor-immune interactions. Join us on Thursday, July 25 at 11 AM EST as our speakers present on: ✔️ The role of the TME in cancer progression and treatment response. ✔️ How mIF can be utilized to simultaneously identify and analyze multiple tumoral and immune cell types. ✔️ Advanced image analysis techniques for assessing intra-tumor heterogeneity and cellular interactions. No matter your background in cancer immunology, prepare to expand your research toolkit!😊💡 Register here: https://bit.ly/3XRbg6tHi #SpatialBiology #CancerImmunology #CancerImmunotherapy #TumorMicroenvironment

Today, on #WorldCancerDay, we stand united in the global effort to fight cancer. We're proud to be part of a community not just witnessing advancements in healthcare; we are helping to drive them. We're honored to spotlight an incredible breakthrough achieved in #lungcancer detection by PrognomiQ Inc’s pioneering study! Using our #ProteographProductSuite, the team brilliantly analyzed over 8,300 protein groups from 2,500 individuals, seamlessly integrating this data with over 200,000 RNA transcripts and 1,000 metabolite measurements. The outcome? A #multiomics classifier that exhibited exceptional sensitivity and high specificity in all-stage lung cancer. Learn more here: https://lnkd.in/geDNawgt These strides in precision medicine are not just scientific achievements; they represent hope and a step closer to personalized care for those bravely battling lung cancer. ❤️ Let's continue to collaborate and innovate for a future where cancer is no longer a life-threatening disease. 🤝🔬 #PrecisionMedicine #Proteomics #CancerResearch #innovationinhealthcare #proteograph #scienceandtechnology

"Empowered by insights at the Cancer Immunology National Workshop hosted by BioTecNika. A profound experience that deepened my understanding of cancer. Eager to translate this knowledge into impactful contributions! 🧬🔬 #CancerImmunology #ContinuousLearning"

🆕 New research by Dr. Stephen-John Sammut et. al. highlights the crucial role of B cells in anticancer immunity! By analyzing B and T cell responses in breast cancer patients, this study shows how B cells CO-EVOLVE with tumors, offering insights into immune surveillance and potential #therapeutic targets. 📚 Read more at: https://lnkd.in/dBRpU2uv ↪ Follow Infinity Bio, Inc. for more immunology discussions #immunology #antibody #biotech #research #academia #immunity #cancer

June 26th marks National Cancer Wellness Awareness Day! 🎗️ Today, we acknowledge the significance of promoting physical, mental, spiritual, and emotional well-being among cancer patients. CanPath is pioneering advancements in cancer research to significantly boost the wellness and quality of life for Canadians living with cancer. 🧬 📺 Revisit some of our previous informative webinars on the impact of our data in cancer research: 🌟 Kimberly Skead presented a webinar on progress towards building the Canadian Cancer Study and how CanPath data and biologics, coupled with linked clinical outcomes, can be used to identify biological signatures associated with increased cancer risk and, subsequently, develop novel early diagnostic tools able to identify cancer years prior to clinical onset: https://lnkd.in/gpw6Nqw3

May is #NationalCancerResearchMonth. According to the American Cancer Society, the advancements being made against cancer, such as improvements in prevention, early detection, and treatment, have resulted in a 33% decrease in the overall cancer death rate since 1991.* To learn more about cancer research, visit bit.ly/4cUBTwr. #ACS #AACR #NationalCancerResearchMonth2024 #NCRM24 #ResearchSavesLives * Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763. PMID: 36633525. The AliyaTM System is 510(k) cleared in the United States for the surgical ablation of soft tissue. It is not currently commercially available in any other geography. Galvanize Therapeutics® does not promote the off-label use of its products and nothing herein is intended to promote an off-label use of the Aliya System. The Aliya System is a tool for the surgical ablation of soft tissues, and is not intended to treat, cure, prevent or mitigate any specific disease or condition.

Attending Northwestern University - The Feinberg School of Medicine's Lung Cancer Symposium in Chicago on Friday, Sept. 6? Come meet Kevin Torres of the #DELFI Key Accounts Partnership team at the DELFI booth. We're delighted to be exhibiting at the Annual Northwestern Medicine Respiratory and Critical Care Symposium, which brings together experts in #pulmonarymedicine, #criticalcaremedicine, and #thoracicsurgery to discuss #evidencebased updates. The Symposium's objectives are to: - Describe and apply a multidisciplinary approach to #lungcancerdiagnosis and management - Examine the role of targeted #biologictherapies in the management of lung cancer - Demonstrate knowledge about the criteria for diagnosis and treatment of lung cancer Join us for this one-day event and participate in critical conversations about the detection, treatment, and management of lung cancer! To learn more or register: https://bit.ly/4e9daEh

⭐ Webinar Alert ⭐ Join us tomorrow to discover how cutting-edge spatially resolved methods can enhance your understanding of the tumor microenvironment, aiding in the development of more effective immunotherapeutic strategies. Whether you're a seasoned researcher or new to cancer immunology, this webinar will equip you with the knowledge and tools to use multiplex immunofluorescence in your research endeavors. Register now: https://bit.ly/3WzMh6A #SpatialBiology #TumorMicroenvironment #Multiplex #Immunofluorescence

Identify the epitopes and T Cell receptors driving the immune response of your clinical research samples. We have partnered with ImmuneWatch to combine their DETECT AI-based software to predict epitope specificity from bulk adaptive immune repertoire sequencing data. Visit us at booth 530 at the Society for Immunotherapy of Cancer (SITC) 2024 annual meeting, or schedule a consultation at https://hubs.li/Q02TQ3LP0 to discuss how to turn adaptive immune repertoires into clinically actionable data for cancer immunotherapy development. #SITC24 #ImmuneWatch #AdaptiveImmuneSystem #Tcell #Epitope #ImmuneRepertoire #AIImmunology